Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Partnering between pharma peers on the rise

Nature Reviews Drug Discovery volume 10, pages 561–562 (2011)Cite this article

Subjects

Pharmaceutical–academia deals have been stealing headlines this year, but more complex models of pharma–pharma collaboration are increasingly being seen as potential solutions to industry's most intractable challenges.

Ten companies are currently in discussions to renew one of the longest standing of such collaborations: the University of Dundee's Division of Signal Transduction Therapy (DSTT; also known as the Dundee Kinase Consortium). Now in its thirteenth year, this forerunner of pharma–pharma–academia partnerships is but one of several thriving experimental models of cooperation. Public research funders and four drug developers are also finalizing an agreement to pool another US$50 million plus in kind contributions into a third round of the Structural Genomics Consortium (SGC). Enlight BioSciences — a company that has taken the novel approach of developing platform technologies based on the needs of a syndicate of industry players and then spinning these out into companies — is in advanced discussions to recruit several new pharmaceutical partners. And GlaxoSmithKline (GSK) and AstraZeneca pitched in a communal UK£10 million in May to create a Centre for Inflammation Research at Manchester University, UK.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mullard, A. Partnering between pharma peers on the rise. Nat Rev Drug Discov 10, 561–562 (2011). https://doi.org/10.1038/nrd3526

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3526

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing